Seeking Alpha

Medtronic (MDT +0.3%) receives FDA and CE Mark approval for its Arctic Front Advance cardiac...

Medtronic (MDT +0.3%) receives FDA and CE Mark approval for its Arctic Front Advance cardiac cryoballoon for the treatment of paroxysmal atrial fibrillation. MDT has the only cryoballoon system currently on the market worldwide, which is purported to provide a more efficient approach to treating the condition than through point-by-point, radiofrequency ablation.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)